ArticleJournal of biochemical and molecular toxicology2023

Gemcitabine resistance in non-small cell lung cancer is mediated through activation of the PI3K/AKT/NF-κB pathway and suppression of ERK signaling by reactive oxygen species.

Chih-Hao Chiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.